Intragastric acid suppression and pharmacokinelics of twice-daily esomeprazole: A randomized, three-way crossover study Academic Article uri icon

Overview

MeSH Major

  • Anti-Ulcer Agents
  • Esomeprazole
  • Gastric Acid
  • Gastroesophageal Reflux

abstract

  • Esomeprazole 40 mg twice daily provides significantly greater acid suppression (number of hours in a 24-h period with pH > 4.0) than once-daily dosing and may be a reasonable consideration for patients requiring greater acid suppression for acid-related disease.

publication date

  • August 15, 2004

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1111/j.1365-2036.2004.02079.x

PubMed ID

  • 15298633

Additional Document Info

start page

  • 399

end page

  • 406

volume

  • 20

number

  • 4